Mizuho Securities Starts Amgen (AMGN) at Buy

November 7, 2016 4:38 PM EST
Get Alerts AMGN Hot Sheet
Price: $152.72 -1.26%

Rating Summary:
    18 Buy, 14 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 17 | New: 14
Trade AMGN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities initiates coverage on Amgen (NASDAQ: AMGN) with a Buy rating and a price target of $164.00.

Analyst Salim Syed highlighted two things:

  • REPATHA. We like the catalysts surrounding Repatha (GLAGOV detailed data Nov 15th @ AHA) and FOURIER (CV outcomes trial 1Q’17)
  • VALUATION. We think the recent price decline may be overblown, but even if we’re wrong, we will likely learn more about Repatha first

For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.

Shares of Amgen closed at $135.40 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Add Your Comment